TR200002271T2 - Fc alıcılarının üç boyutlu yapıları ve modelleri ve bunların kullanımı - Google Patents

Fc alıcılarının üç boyutlu yapıları ve modelleri ve bunların kullanımı

Info

Publication number
TR200002271T2
TR200002271T2 TR2000/02271T TR200002271T TR200002271T2 TR 200002271 T2 TR200002271 T2 TR 200002271T2 TR 2000/02271 T TR2000/02271 T TR 2000/02271T TR 200002271 T TR200002271 T TR 200002271T TR 200002271 T2 TR200002271 T2 TR 200002271T2
Authority
TR
Turkey
Prior art keywords
models
fcgammariia
crystals
protein
dimensional coordinates
Prior art date
Application number
TR2000/02271T
Other languages
English (en)
Inventor
Mark Hogarth P.
S. Powell Maree
F.C. Mckenzie Ian
F. Maxwell Kelly
P.J. Garrett Thomas
Epa Vidana
B. Baell Jonathan
R. Matthews Barry
D. Mccarthy Thomas
A. Pietersz Geoffrey
Original Assignee
Ilexus Pty Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ilexus Pty Limited filed Critical Ilexus Pty Limited
Publication of TR200002271T2 publication Critical patent/TR200002271T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

Kristaller, kristal yapili FcgammaRIIa proteini, FcgammaRIIa proteininin üç boyutlu koordinatlari, ve FcgammaRIIa yapisindan türetilmis yapi ve modeller sunulmustur. Ayrica FcepsilonRI proteininin kristalleri ve FcgammaRIIa yapisinda türetilmis FcepsilonRI protein monomerleri ve dimerlerine ait üç boyutlu koordinatlar da ortaya konulmustur. Ayrica FcgammaRIIIb proteinlerinin üç boyutlu koordinatlari ve FcgammaRIIa yapisindan türetilmis FcgammaRIIIb modelleri de gösterilmistir. Mevcut bulus, bu kristallerin, kristal yapilarinin ve modellerin üretilmesine yönelik metotlari da kapsar. Yapi bazinda ilaç tasarimi ve terapötik kompozisyonlar dahil olmak üzere bu gibi kristallerin, kristal yapilarinin ve modellerin kullanimlari da sunulmustur.
TR2000/02271T 1998-02-06 1999-02-04 Fc alıcılarının üç boyutlu yapıları ve modelleri ve bunların kullanımı TR200002271T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7397298P 1998-02-06 1998-02-06
US9999498P 1998-09-11 1998-09-11

Publications (1)

Publication Number Publication Date
TR200002271T2 true TR200002271T2 (tr) 2000-11-21

Family

ID=26755120

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02271T TR200002271T2 (tr) 1998-02-06 1999-02-04 Fc alıcılarının üç boyutlu yapıları ve modelleri ve bunların kullanımı

Country Status (16)

Country Link
US (2) US6675105B2 (tr)
EP (1) EP1053255A4 (tr)
JP (1) JP2004510681A (tr)
KR (1) KR20010024899A (tr)
CN (1) CN1291198A (tr)
AP (1) AP2000001876A0 (tr)
AU (1) AU759378B2 (tr)
BR (1) BR9907964A (tr)
CA (1) CA2316860A1 (tr)
EA (1) EA200000746A1 (tr)
IL (1) IL137583A0 (tr)
NO (1) NO20003964L (tr)
NZ (1) NZ505914A (tr)
PL (1) PL342297A1 (tr)
TR (1) TR200002271T2 (tr)
WO (1) WO1999040117A1 (tr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553809B2 (en) 1998-02-06 2009-06-30 Ilexus Pty Limited Fc receptor modulators and uses thereof
CN1189166C (zh) 1998-09-11 2005-02-16 伊来克萨斯独资有限公司 Fc受体调节剂及其应用
JP2002533060A (ja) * 1998-11-05 2002-10-08 ヘスカ コーポレイション 結晶化型のＦｃイプシロンレセプタアルファ鎖、その３−Ｄモデル、及びそれらの利用法
EP1006183A1 (en) * 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant soluble Fc receptors
US7912689B1 (en) 1999-02-11 2011-03-22 Cambridgesoft Corporation Enhancing structure diagram generation through use of symmetry
US7295931B1 (en) * 1999-02-18 2007-11-13 Cambridgesoft Corporation Deriving fixed bond information
US6850876B1 (en) * 1999-05-04 2005-02-01 Smithkline Beecham Corporation Cell based binning methods and cell coverage system for molecule selection
US6889145B1 (en) 2000-03-15 2005-05-03 Northwestern University Three-dimensional model of a Fc region of an IgE antibody and uses thereof
US7356419B1 (en) 2000-05-05 2008-04-08 Cambridgesoft Corporation Deriving product information
US7272509B1 (en) * 2000-05-05 2007-09-18 Cambridgesoft Corporation Managing product information
GB0029871D0 (en) * 2000-07-14 2001-01-24 Medical Res Council Crystal structure (V)
IL144082A0 (en) * 2000-07-14 2002-05-23 Medical Res Council Crystal structure of antibiotics bound to the 30s ribosome and its use
EP1201681A1 (en) 2000-10-30 2002-05-02 Millennium Pharmaceuticals, Inc. "Fail" molecules and uses thereof
CN1245215C (zh) 2001-02-28 2006-03-15 四川省生物工程研究中心 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
MXPA03009580A (es) * 2001-04-20 2004-12-06 Sinai School Medicine Tir3, un receptor de sabor novedoso.
EP2335728A1 (en) * 2001-05-11 2011-06-22 Ludwig Institute for Cancer Research Ltd. Specific binding proteins and uses thereof
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
DE10157290A1 (de) * 2001-11-22 2003-06-05 Max Planck Gesellschaft Pharmazeutische Zusammensetzung enthaltend sFcRgamma IIb oder sFcRgamma III
CA2480202A1 (en) * 2002-04-10 2003-10-23 Transtech Pharma, Inc. System and method for data analysis, manipulation, and visualization
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
EP2272533A1 (en) 2003-01-13 2011-01-12 MacroGenics, Inc. Soluble FcyR fusion proteins and methods of use thereof
AU2004241060B2 (en) * 2003-05-26 2009-07-23 Biotie Therapies Corp. Crystalline VAP-1 and uses thereof
US7585647B2 (en) 2003-08-28 2009-09-08 Guangwen Wei Nucleic acid encoding recombinant interferon
JP2008512083A (ja) * 2004-02-10 2008-04-24 ジ・オースティン・リサーチ・インスティテュート Ｆｃ受容体の結晶構造およびモデルならびにＦｃ受容体モジュレーター化合物の設計および同定におけるそれらの使用
WO2006133486A1 (en) * 2005-06-14 2006-12-21 The Macfarlane Burnet Institute For Medical Research And Public Health Limited CRYSTAL STRUCTURES AND MODELS FOR Fc RECEPTOR:Fc COMPLEXES AND USES THEREOF
WO2008103474A1 (en) 2007-02-20 2008-08-28 Anaptysbio, Inc. Methods of generating libraries and uses thereof
CA2798294C (en) * 2010-05-03 2019-05-28 Cambridgesoft Corporation Method and apparatus for processing documents to identify chemical structures
RU2641256C2 (ru) 2011-06-30 2018-01-16 Чугаи Сейяку Кабусики Кайся Гетеродимеризованный полипептид
US9977876B2 (en) 2012-02-24 2018-05-22 Perkinelmer Informatics, Inc. Systems, methods, and apparatus for drawing chemical structures using touch and gestures
JP6628966B2 (ja) 2012-06-14 2020-01-15 中外製薬株式会社 改変されたＦｃ領域を含む抗原結合分子
RU2729831C2 (ru) 2012-08-24 2020-08-12 Чугаи Сейяку Кабусики Кайся ВАРИАНТЫ FcγRIIB-СПЕЦИФИЧЕСКОЙ Fc-ОБЛАСТИ
US9535583B2 (en) 2012-12-13 2017-01-03 Perkinelmer Informatics, Inc. Draw-ahead feature for chemical structure drawing applications
US10766960B2 (en) 2012-12-27 2020-09-08 Chugai Seiyaku Kabushiki Kaisha Heterodimerized polypeptide
WO2014163749A1 (en) 2013-03-13 2014-10-09 Cambridgesoft Corporation Systems and methods for gesture-based sharing of data between separate electronic devices
US8854361B1 (en) 2013-03-13 2014-10-07 Cambridgesoft Corporation Visually augmenting a graphical rendering of a chemical structure representation or biological sequence representation with multi-dimensional information
EP3783017A1 (en) 2013-04-02 2021-02-24 Chugai Seiyaku Kabushiki Kaisha Fc region variant
US9430127B2 (en) 2013-05-08 2016-08-30 Cambridgesoft Corporation Systems and methods for providing feedback cues for touch screen interface interaction with chemical and biological structure drawing applications
US9751294B2 (en) 2013-05-09 2017-09-05 Perkinelmer Informatics, Inc. Systems and methods for translating three dimensional graphic molecular models to computer aided design format
CA3041717A1 (en) 2016-11-09 2018-05-17 North Carolina State University Treatment of allergic diseases with chimeric protein
CA3055172C (en) 2017-03-03 2022-03-01 Perkinelmer Informatics, Inc. Systems and methods for searching and indexing documents comprising chemical information
KR101986250B1 (ko) * 2017-09-15 2019-06-05 국민대학교 산학협력단 Fc 감마 수용체 변이체 SH2A40
KR101987279B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A45.1
KR101987268B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A45
KR101987272B1 (ko) * 2017-09-15 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A28.1
KR101987292B1 (ko) * 2017-10-12 2019-06-10 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2B45.1
KR101986252B1 (ko) * 2017-09-15 2019-06-05 국민대학교 산학협력단 Fc 감마 수용체 변이체 MG2A28
BR112020000098A2 (pt) * 2017-09-15 2020-07-14 Kookmin University Industry Academy Cooperation Foundation mutantes de receptor fc-gama
WO2019183437A1 (en) * 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
CN115035947B (zh) * 2022-06-10 2023-03-10 水木未来(北京)科技有限公司 蛋白质结构建模方法及装置、电子设备和存储介质

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858981A (en) * 1993-09-30 1999-01-12 University Of Pennsylvania Method of inhibiting phagocytosis
CN1189166C (zh) * 1998-09-11 2005-02-16 伊来克萨斯独资有限公司 Fc受体调节剂及其应用
AU2001278771A1 (en) * 2000-08-22 2002-03-04 Ono Pharmaceutical Co. Ltd. Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient

Also Published As

Publication number Publication date
EA200000746A1 (ru) 2001-04-23
EP1053255A4 (en) 2003-01-02
US20040054480A1 (en) 2004-03-18
US6675105B2 (en) 2004-01-06
EP1053255A1 (en) 2000-11-22
PL342297A1 (en) 2001-06-04
BR9907964A (pt) 2000-10-17
NO20003964D0 (no) 2000-08-04
KR20010024899A (ko) 2001-03-26
AU2438299A (en) 1999-08-23
CN1291198A (zh) 2001-04-11
CA2316860A1 (en) 1999-08-12
US20020107359A1 (en) 2002-08-08
WO1999040117A1 (en) 1999-08-12
AP2000001876A0 (en) 2000-09-30
NO20003964L (no) 2000-10-04
NZ505914A (en) 2004-03-26
IL137583A0 (en) 2001-07-24
AU759378B2 (en) 2003-04-10
JP2004510681A (ja) 2004-04-08

Similar Documents

Publication Publication Date Title
TR200002271T2 (tr) Fc alıcılarının üç boyutlu yapıları ve modelleri ve bunların kullanımı
PT735818E (pt) Proteinas inflamatorias de macrofagos pim-3 pim-4 e pim-1y
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
TR199800012T1 (tr) Piroloprimidinler ve preparasyon için tatbikler.
DK1200479T3 (da) Multiple cytokin-antistof-komplekser
DE69412552D1 (de) Medizinisches Instrument zur Behandlung von Sinusitis
DE69634572D1 (de) Perfusionssytem zur hyperthermiebehandlung
NL7800767A (nl) Additieverbinding van dipeptidederivaat en aminozuurderivaat evenals de werkwijze voor de bereiding hiervan.
BR0107613A (pt) Bloqueio do crescimento de axÈnios mediado por receptor nogo
MXPA05007182A (es) Complejos de cristales de proteina y polimeros ionicos.
DE68925857D1 (de) System zur Korrektur des Ausdehnungsgrades von Bildern
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
AU9363398A (en) Hepatitis c receptor protein cd81
BR0312889A (pt) Polipeptìdeo t20 peguilado
DK0553294T3 (da) Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE68921229T2 (de) Prozess zur Behandlung von unlöslichem heterogenem Fusionsprotein.
NO904292L (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
WO2003004517A3 (en) Peyers's patch and/or m-celle targeting ligands
DK675389A (da) Terapeutiske praeparater til forebyggelse af fibrinaflejringer
AU1998995A (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
NO894880L (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
ATE230263T1 (de) At1 rezeptor antagonist zur anregung von apoptosis